đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This low interventional study aims to describe if and how the haemophilia t...
Status
Completed
Location
Swedish Orphan Biovitrum Research site
Start Date
2020-01-13
Trial ID
NCT04133883
Treatments Being Tested
Study Design A prospective observational, cross-sectional epidemiological ...
Status
Terminated
Location
University of Florida College of Medicine
Start Date
2017-09-01
Trial ID
NCT03248141
Alprolix (rFIXFc) is a recombinant extended half-life coagulation factor pr...
Status
Completed
Location
Swedish Orphan Biovitrum Research Site (CHU de Bordeaux)
Start Date
2018-09-12
Trial ID
NCT03655340
Treatments Being Tested
The main aims of the study are to assess the safety profile of Adynovate as...
Status
Completed
Location
Hamilton-Niagara Regional Hemophilia Treatment Centre
Start Date
2021-11-30
Trial ID
NCT04876365
Treatments Being Tested
This is a 48-month observational, prospective, multicentre study. The overa...
Status
Active Not Recruiting
Location
University Hospital Brno
Start Date
2020-03-30
Trial ID
NCT04293523
Treatments Being Tested
Alprolix (rFIXFc) is a recombinant extended half-life coagulation factor pr...
Status
Completed
Location
Swedish Orphan Biovitrum Research Site
Start Date
2019-09-12
Trial ID
NCT03901755
Treatments Being Tested
Low dose factor VIII prophylaxis is practiced around the world. Role of sta...
Status
Not Yet Recruiting
Location
Dhaka Medical College Hospital
Start Date
2025-06-01
Trial ID
NCT06938659
Treatments Being Tested
Individualised pharmacokinetic (PK)-guided dosing of extended half-life (EH...
Status
Completed
Location
Pediatric department, Faculty of medicine, Chulalongkorn University
Start Date
2021-07-01
Trial ID
NCT05281185
Patients with severe hemophilia A often develop joint complication requirin...
Status
Enrolling By Invitation
Location
Pediatric Department, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital
Start Date
2024-04-01
Trial ID
NCT06816953
The purpose of the study is to evaluate the effectiveness of Elocta compare...
Status
Completed
Location
Swedish Orphan Biovitrum Research site
Start Date
2016-12
Trial ID
NCT02976753
Treatments Being Tested